COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse events
Individuals who experience severe COVID-19-vaccine-related adverse reactions such as transverse myelitis may be precluded from receiving further vaccination to protect from SARS-CoV-2 infection. Although the mechanism of autoimmune spinal cord inflammation resulting in transverse myelitis is unclear...
Saved in:
Main Author: | William E. Fitzsimmons (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MMR Vaccine and Transverse Myelitis
by: J Gordon Millichap
Published: (1995) -
Longitudinally extensive transverse myelitis after covid vaccination: Response to letter
by: Seyed Farzad Maroufi, et al.
Published: (2022) -
SARS-CoV-2 vaccinations complicated by transverse myelitis
by: Josef Finsterer
Published: (2022) -
A case of acute transverse myelitis following the AstraZeneca COVID-19 vaccine
by: Reema Madike, et al.
Published: (2023) -
Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature
by: Seyed Farzad Maroufi, et al.
Published: (2022)